Greenwich Lifesciences, Inc. (GLSI) — 10-Q Filings

10-Q Filings (6)

• GLSI's Losses Mount 48% Amid Soaring R&D Costs, Cash Dwindles — Nov 14, 2025 Risk: high
  Greenwich LifeSciences, Inc. reported a net loss of $11,435,485 for the nine months ended September 30, 2025, a significant increase from the $7,748,590 net los
• GLSI's Losses Widen 43% Amid Soaring R&D, G&A Costs — Aug 14, 2025 Risk: high
  Greenwich LifeSciences, Inc. (GLSI) reported no revenue for the three and six months ended June 30, 2025, consistent with the prior year. The company experience
• Greenwich LifeSciences Files Q1 2025 10-Q — May 20, 2025 Risk: medium
  Greenwich LifeSciences, Inc. filed its Q1 2025 10-Q report on May 20, 2025, covering the period ending March 31, 2025. The company, based in Stafford, Texas, op
• Greenwich LifeSciences Files Q3 2024 10-Q Report — Nov 14, 2024 Risk: medium
  Greenwich LifeSciences, Inc. filed its Q3 10-Q report on November 14, 2024, covering the period ending September 30, 2024. The company, based in Stafford, TX, o
• Greenwich LifeSciences Files Q2 2024 10-Q — Aug 14, 2024 Risk: medium
  Greenwich LifeSciences, Inc. filed its 10-Q for the period ending June 30, 2024. The company, based in Stafford, TX, operates in the Pharmaceutical Preparations
• Greenwich LifeSciences Files Q1 2024 10-Q — May 20, 2024 Risk: medium
  Greenwich LifeSciences, Inc. filed its Q1 2024 10-Q report on May 20, 2024, detailing its financial performance for the period ending March 31, 2024. The compan

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX